カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ヒト絨毛性ゴナドトロピン（HCG）の世界市場見通し2023年-2029年

◆英語タイトル：Human Chorionic Gonadotrophin (HCG) Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8774 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：61 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Human Chorionic Gonadotrophin (HCG) Market 調査レポートは次の情報を含め、グローバルにおけるのヒト絨毛性ゴナドトロピン（HCG）市場規模と予測を収録しています。・世界のヒト絨毛性ゴナドトロピン（HCG）市場：売上、2018年-2023年、2024年-2029年
・世界のヒト絨毛性ゴナドトロピン（HCG）市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のヒト絨毛性ゴナドトロピン（HCG）市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「u-hCG」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

ヒト絨毛性ゴナドトロピン（HCG）のグローバル主要企業は、Qingdao Kangyuan Pharmaceutical Co., Ltd.、 Ningbo Renjian Pharmaceutical Group Co., Ltd.、 Jiangxi Haoran Biopharmaceutical Co., Ltd.、 Shanghai Tianwei Biopharmaceutical Co., Ltd.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、ヒト絨毛性ゴナドトロピン（HCG）のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のヒト絨毛性ゴナドトロピン（HCG）市場：タイプ別、2018年-2023年、2024年-2029年
世界のヒト絨毛性ゴナドトロピン（HCG）市場：タイプ別市場シェア、2022年
・u-hCG、r-hCG

世界のヒト絨毛性ゴナドトロピン（HCG）市場：用途別、2018年-2023年、2024年-2029年
世界のヒト絨毛性ゴナドトロピン（HCG）市場：用途別市場シェア、2022年
・医薬品、妊娠検査薬、その他

世界のヒト絨毛性ゴナドトロピン（HCG）市場：地域・国別、2018年-2023年、2024年-2029年
世界のヒト絨毛性ゴナドトロピン（HCG）市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるヒト絨毛性ゴナドトロピン（HCG）のグローバル売上、2018年-2023年
・主要企業におけるヒト絨毛性ゴナドトロピン（HCG）のグローバル売上シェア、2022年
・主要企業におけるヒト絨毛性ゴナドトロピン（HCG）のグローバル販売量、2018年-2023年
・主要企業におけるヒト絨毛性ゴナドトロピン（HCG）のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Qingdao Kangyuan Pharmaceutical Co., Ltd.、 Ningbo Renjian Pharmaceutical Group Co., Ltd.、 Jiangxi Haoran Biopharmaceutical Co., Ltd.、 Shanghai Tianwei Biopharmaceutical Co., Ltd.

*************************************************************

・調査・分析レポートの概要
ヒト絨毛性ゴナドトロピン（HCG）市場の定義
市場セグメント
世界のヒト絨毛性ゴナドトロピン（HCG）市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のヒト絨毛性ゴナドトロピン（HCG）市場規模
世界のヒト絨毛性ゴナドトロピン（HCG）市場規模：2022年 VS 2029年
世界のヒト絨毛性ゴナドトロピン（HCG）市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのヒト絨毛性ゴナドトロピン（HCG）の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のヒト絨毛性ゴナドトロピン（HCG）製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：u-hCG、r-hCG
ヒト絨毛性ゴナドトロピン（HCG）のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：医薬品、妊娠検査薬、その他
ヒト絨毛性ゴナドトロピン（HCG）の用途別グローバル売上・予測

・地域別市場分析
地域別ヒト絨毛性ゴナドトロピン（HCG）市場規模 2022年と2029年
地域別ヒト絨毛性ゴナドトロピン（HCG）売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Qingdao Kangyuan Pharmaceutical Co., Ltd.、 Ningbo Renjian Pharmaceutical Group Co., Ltd.、 Jiangxi Haoran Biopharmaceutical Co., Ltd.、 Shanghai Tianwei Biopharmaceutical Co., Ltd.
...

This report aims to provide a comprehensive presentation of the global market for Human Chorionic Gonadotrophin (HCG), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Chorionic Gonadotrophin (HCG). This report contains market size and forecasts of Human Chorionic Gonadotrophin (HCG) in global, including the following market information:
Global Human Chorionic Gonadotrophin (HCG) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Human Chorionic Gonadotrophin (HCG) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
u-hCG Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Chorionic Gonadotrophin (HCG) include Qingdao Kangyuan Pharmaceutical Co., Ltd., Ningbo Renjian Pharmaceutical Group Co., Ltd., Jiangxi Haoran Biopharmaceutical Co., Ltd. and Shanghai Tianwei Biopharmaceutical Co., Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Chorionic Gonadotrophin (HCG) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Chorionic Gonadotrophin (HCG) Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Human Chorionic Gonadotrophin (HCG) Market Segment Percentages, by Type, 2022 (%)
u-hCG
r-hCG
Global Human Chorionic Gonadotrophin (HCG) Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Human Chorionic Gonadotrophin (HCG) Market Segment Percentages, by Application, 2022 (%)
Drug
Pregnancy Test Paper
Other
Global Human Chorionic Gonadotrophin (HCG) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Human Chorionic Gonadotrophin (HCG) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Chorionic Gonadotrophin (HCG) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Human Chorionic Gonadotrophin (HCG) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Qingdao Kangyuan Pharmaceutical Co., Ltd.
Ningbo Renjian Pharmaceutical Group Co., Ltd.
Jiangxi Haoran Biopharmaceutical Co., Ltd.
Shanghai Tianwei Biopharmaceutical Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Chorionic Gonadotrophin (HCG), market overview.
Chapter 2: Global Human Chorionic Gonadotrophin (HCG) market size in revenue.
Chapter 3: Detailed analysis of Human Chorionic Gonadotrophin (HCG) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Chorionic Gonadotrophin (HCG) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Human Chorionic Gonadotrophin (HCG) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Chorionic Gonadotrophin (HCG) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Chorionic Gonadotrophin (HCG) Overall Market Size
2.1 Global Human Chorionic Gonadotrophin (HCG) Market Size: 2022 VS 2029
2.2 Global Human Chorionic Gonadotrophin (HCG) Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human Chorionic Gonadotrophin (HCG) Players in Global Market
3.2 Top Global Human Chorionic Gonadotrophin (HCG) Companies Ranked by Revenue
3.3 Global Human Chorionic Gonadotrophin (HCG) Revenue by Companies
3.4 Top 3 and Top 5 Human Chorionic Gonadotrophin (HCG) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Human Chorionic Gonadotrophin (HCG) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Chorionic Gonadotrophin (HCG) Players in Global Market
3.6.1 List of Global Tier 1 Human Chorionic Gonadotrophin (HCG) Companies
3.6.2 List of Global Tier 2 and Tier 3 Human Chorionic Gonadotrophin (HCG) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Human Chorionic Gonadotrophin (HCG) Market Size Markets, 2022 & 2029
4.1.2 u-hCG
4.1.3 r-hCG
4.2 By Type – Global Human Chorionic Gonadotrophin (HCG) Revenue & Forecasts
4.2.1 By Type – Global Human Chorionic Gonadotrophin (HCG) Revenue, 2018-2023
4.2.2 By Type – Global Human Chorionic Gonadotrophin (HCG) Revenue, 2024-2029
4.2.3 By Type – Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Human Chorionic Gonadotrophin (HCG) Market Size, 2022 & 2029
5.1.2 Drug
5.1.3 Pregnancy Test Paper
5.1.4 Other
5.2 By Application – Global Human Chorionic Gonadotrophin (HCG) Revenue & Forecasts
5.2.1 By Application – Global Human Chorionic Gonadotrophin (HCG) Revenue, 2018-2023
5.2.2 By Application – Global Human Chorionic Gonadotrophin (HCG) Revenue, 2024-2029
5.2.3 By Application – Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Human Chorionic Gonadotrophin (HCG) Market Size, 2022 & 2029
6.2 By Region – Global Human Chorionic Gonadotrophin (HCG) Revenue & Forecasts
6.2.1 By Region – Global Human Chorionic Gonadotrophin (HCG) Revenue, 2018-2023
6.2.2 By Region – Global Human Chorionic Gonadotrophin (HCG) Revenue, 2024-2029
6.2.3 By Region – Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Human Chorionic Gonadotrophin (HCG) Revenue, 2018-2029
6.3.2 US Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.3.3 Canada Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.3.4 Mexico Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Human Chorionic Gonadotrophin (HCG) Revenue, 2018-2029
6.4.2 Germany Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.4.3 France Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.4.4 U.K. Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.4.5 Italy Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.4.6 Russia Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.4.7 Nordic Countries Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.4.8 Benelux Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Human Chorionic Gonadotrophin (HCG) Revenue, 2018-2029
6.5.2 China Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.5.3 Japan Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.5.4 South Korea Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.5.5 Southeast Asia Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.5.6 India Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Human Chorionic Gonadotrophin (HCG) Revenue, 2018-2029
6.6.2 Brazil Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.6.3 Argentina Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Human Chorionic Gonadotrophin (HCG) Revenue, 2018-2029
6.7.2 Turkey Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.7.3 Israel Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.7.4 Saudi Arabia Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
6.7.5 UAE Human Chorionic Gonadotrophin (HCG) Market Size, 2018-2029
7 Human Chorionic Gonadotrophin (HCG) Companies Profiles
7.1 Qingdao Kangyuan Pharmaceutical Co., Ltd.
7.1.1 Qingdao Kangyuan Pharmaceutical Co., Ltd. Company Summary
7.1.2 Qingdao Kangyuan Pharmaceutical Co., Ltd. Business Overview
7.1.3 Qingdao Kangyuan Pharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Major Product Offerings
7.1.4 Qingdao Kangyuan Pharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue in Global Market (2018-2023)
7.1.5 Qingdao Kangyuan Pharmaceutical Co., Ltd. Key News & Latest Developments
7.2 Ningbo Renjian Pharmaceutical Group Co., Ltd.
7.2.1 Ningbo Renjian Pharmaceutical Group Co., Ltd. Company Summary
7.2.2 Ningbo Renjian Pharmaceutical Group Co., Ltd. Business Overview
7.2.3 Ningbo Renjian Pharmaceutical Group Co., Ltd. Human Chorionic Gonadotrophin (HCG) Major Product Offerings
7.2.4 Ningbo Renjian Pharmaceutical Group Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue in Global Market (2018-2023)
7.2.5 Ningbo Renjian Pharmaceutical Group Co., Ltd. Key News & Latest Developments
7.3 Jiangxi Haoran Biopharmaceutical Co., Ltd.
7.3.1 Jiangxi Haoran Biopharmaceutical Co., Ltd. Company Summary
7.3.2 Jiangxi Haoran Biopharmaceutical Co., Ltd. Business Overview
7.3.3 Jiangxi Haoran Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Major Product Offerings
7.3.4 Jiangxi Haoran Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue in Global Market (2018-2023)
7.3.5 Jiangxi Haoran Biopharmaceutical Co., Ltd. Key News & Latest Developments
7.4 Shanghai Tianwei Biopharmaceutical Co., Ltd.
7.4.1 Shanghai Tianwei Biopharmaceutical Co., Ltd. Company Summary
7.4.2 Shanghai Tianwei Biopharmaceutical Co., Ltd. Business Overview
7.4.3 Shanghai Tianwei Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Major Product Offerings
7.4.4 Shanghai Tianwei Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue in Global Market (2018-2023)
7.4.5 Shanghai Tianwei Biopharmaceutical Co., Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Human Chorionic Gonadotrophin (HCG) Market Opportunities & Trends in Global Market
Table 2. Human Chorionic Gonadotrophin (HCG) Market Drivers in Global Market
Table 3. Human Chorionic Gonadotrophin (HCG) Market Restraints in Global Market
Table 4. Key Players of Human Chorionic Gonadotrophin (HCG) in Global Market
Table 5. Top Human Chorionic Gonadotrophin (HCG) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Human Chorionic Gonadotrophin (HCG) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Human Chorionic Gonadotrophin (HCG) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Human Chorionic Gonadotrophin (HCG) Product Type
Table 9. List of Global Tier 1 Human Chorionic Gonadotrophin (HCG) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Chorionic Gonadotrophin (HCG) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Human Chorionic Gonadotrophin (HCG) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Human Chorionic Gonadotrophin (HCG) Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Human Chorionic Gonadotrophin (HCG) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Human Chorionic Gonadotrophin (HCG) Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Human Chorionic Gonadotrophin (HCG) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Human Chorionic Gonadotrophin (HCG) Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2024-2029
Table 30. Qingdao Kangyuan Pharmaceutical Co., Ltd. Company Summary
Table 31. Qingdao Kangyuan Pharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product Offerings
Table 32. Qingdao Kangyuan Pharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue (US$, Mn) & (2018-2023)
Table 33. Qingdao Kangyuan Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 34. Ningbo Renjian Pharmaceutical Group Co., Ltd. Company Summary
Table 35. Ningbo Renjian Pharmaceutical Group Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product Offerings
Table 36. Ningbo Renjian Pharmaceutical Group Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue (US$, Mn) & (2018-2023)
Table 37. Ningbo Renjian Pharmaceutical Group Co., Ltd. Key News & Latest Developments
Table 38. Jiangxi Haoran Biopharmaceutical Co., Ltd. Company Summary
Table 39. Jiangxi Haoran Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product Offerings
Table 40. Jiangxi Haoran Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue (US$, Mn) & (2018-2023)
Table 41. Jiangxi Haoran Biopharmaceutical Co., Ltd. Key News & Latest Developments
Table 42. Shanghai Tianwei Biopharmaceutical Co., Ltd. Company Summary
Table 43. Shanghai Tianwei Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Product Offerings
Table 44. Shanghai Tianwei Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue (US$, Mn) & (2018-2023)
Table 45. Shanghai Tianwei Biopharmaceutical Co., Ltd. Key News & Latest Developments
List of Figures
Figure 1. Human Chorionic Gonadotrophin (HCG) Segment by Type in 2022
Figure 2. Human Chorionic Gonadotrophin (HCG) Segment by Application in 2022
Figure 3. Global Human Chorionic Gonadotrophin (HCG) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Chorionic Gonadotrophin (HCG) Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Human Chorionic Gonadotrophin (HCG) Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Human Chorionic Gonadotrophin (HCG) Revenue in 2022
Figure 8. By Type - Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share, 2018-2029
Figure 9. By Application - Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share, 2018-2029
Figure 10. By Type - Global Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share, 2018-2029
Figure 12. By Application - Global Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share, 2018-2029
Figure 14. By Region - Global Human Chorionic Gonadotrophin (HCG) Revenue Market Share, 2018-2029
Figure 15. By Country - North America Human Chorionic Gonadotrophin (HCG) Revenue Market Share, 2018-2029
Figure 16. US Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Human Chorionic Gonadotrophin (HCG) Revenue Market Share, 2018-2029
Figure 20. Germany Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 21. France Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Human Chorionic Gonadotrophin (HCG) Revenue Market Share, 2018-2029
Figure 28. China Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 32. India Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Human Chorionic Gonadotrophin (HCG) Revenue Market Share, 2018-2029
Figure 34. Brazil Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Human Chorionic Gonadotrophin (HCG) Revenue Market Share, 2018-2029
Figure 37. Turkey Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Human Chorionic Gonadotrophin (HCG) Revenue, (US$, Mn), 2018-2029
Figure 41. Qingdao Kangyuan Pharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Ningbo Renjian Pharmaceutical Group Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Jiangxi Haoran Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Shanghai Tianwei Biopharmaceutical Co., Ltd. Human Chorionic Gonadotrophin (HCG) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ヒト絨毛性ゴナドトロピン（HCG）の世界市場見通し2023年-2029年(Human Chorionic Gonadotrophin (HCG) Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

ヒト絨毛性ゴナドトロピン（HCG）の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp